Cardiogramme Echographie Salle d'opération Salle d'opération
Logo   Accueil | Table des matières | Téléchargements | Liens |   Mentions légales   | Contact |Abréviations
Logo  

Bibliographie

Lectures conseillées

BERNSTEIN AD, DAUBERT JC, FLETCHER RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptative-rate, and multisite pacing. North American Society of Pacing and Electrophysiology / British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 2002; 25:260-4
CHRIST M, SHARKOVA Y, GELDNER G, MAISCH B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest 2005; 128:2944-53
EBERLI D, CHASSOT PG, SULSER T et al. Urologic surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol 2010; 183:2128-36
FLEISHER LA, FLEISCHMANN KE, AUERBACH AD, et al. 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130:000-000
FROEHLICH JB, FLEISCHER LA. Noncardiac surgery in the patient with heart disease. Anesthesiol Clin 2009; 27:649-71
KORTE W, CATTANEO M, CHASSOT PG, et al. Perioperative management of antiplatelet therapy in patients with coronary artery disease. Thromb Haemost 2011; 105: 743-9
KRISTENSEN SD, KNUUTI J, SARASTE A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J 2014; 35:2383-431
PRIEBE HJ. Preoperative cardiac management of the patient for non-cardiac surgery: an individualized and evidence-based approach. Br J Anaesth 2011; 107:83-96
WIJEYSUNDERA DN, DUNCAN D, NKONDE-PRICE, et al. Perioperative beta-blockade in noncardiac surgery: A systematic review for the 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130:000-000

 

Références

1 ALBALADEJO P, MARRET E, SAMAMA CM, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart 2011; 97:1566-72
1a AFILALO J, ALEXANDER KP, MACK MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol 2014; 63:747-62
2 ALLAN GM, NOURI F, KOROWNYK C, et al. Agreement among cardiovascular disease risk calculators. Circulation 2013 ; 127 :1948-56
3 Angiolillo DJ, BHATT DL, GURBEL PA JENNINGS LK. Advances in antiplatelet therapy: agents in clinical development. Am J Cardiol 2009; 103(suppl):40A-51A
4 Angiolillo DJ, FIRSTENBERG MS, PRICE MJ, et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery. JAMA 2012; 307:265-74
5 ARMSTRONG EJ, RUTLEDGE JC, ROGERS JH. Coronary artery revascularization in patients with diabetes mellitus. Circulation 2013; 128:1675-85
6 ATC - Antithrombotic Trialist’s Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86
7 ATLEE JL. Cardiac arrhythmias: drugs and devices. Curr Opin Anaesthesiol 2001; 14:3-9
8 ATLEE JL, BERNSTEIN A. Cardiac rhythm management devices (Part II). Anesthesiology 2001; 95:1492-1506
9 BADNER NH. KNILL TL, BROWN JE, et al. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88:572-8
10 BANGALORE S, WETTERSLEV J, PRANESH S, et al. Perioperative  blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008; 372:1962-76
11 BARI Investigators. The Bypass Angioplasty Revascularization Investigation investigators. Seven-year outcome in the bypass angioplasty revascularization investigation by treatment and diabetes staus. J Am Coll Cardiol 2000; 35:1122-9
12 BARON TH, KAMATH PS, McBANE RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med 2013; 368:2113-24
13 BAUER T, BOUMAN HJ, VAN WERKUM JW, et al. Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. Br Med J 2011; 343:d4588
14 BAUER S, CAYNE NS, VEITH FJ. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg 2010; 51:242-51
15 BEATTIE WS, ABDELNAEM E, WIJEYSUNDERA DN, BUCKLEY DN. A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesth Analg 2006; 102:8-16
16 BEATTIE WS, WIJEYSUNDERA DN, KARKOUTI K, et al. Acute surgical aneamia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology 2010; 112:25-33
17 BERGER JS, FRYE CB, HARSHAW Q, et al. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery. J Am Coll Cardiol 2008; 52:1693-701
18 BERNSTEIN AD, DAUBERT JC, FLETCHER RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptative-rate, and multisite pacing. North American Society of Pacing and Electrophysiology / British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 2002; 25:260-4
19 BERRY C, DOUGHTY RN, GRANGER C, et al. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patients meta-analysis. Eur Heart J 3012; 33:1750-7
20 BHATT DL, STONE GW, MAHAFFEY KW, et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 2013; 368:1303-13
21 BICCARD BM. Peri-operative -blockade and haemodynamic optimisation in patients with coronary artery disease and decreasing exercise capacity presenting for major noncardiac surgery. Anaesthesia 2004; 59:60-8
21a BICCARD BM. Proposed research plan for the derivation of a new cardiac risk index. Anesth Analg 2015; 120:543-53
22 BICCARD BM, RODSETH R. A meta-analysis of the prospective randomised trials of coronary revascularisation before noncardiac vascular surgery with attention to the type of coronary revascularisation performed. Anaesthesia 2009; 64:1105-13
23 BICCARD BM, RODSETH R. Utility of clinical risk predictors for perioperative cardiovascular risk prediction. Br J Anaesth 2011; 107:133-43
24 BILLINGS FT. Early postoperative statin therapy is asociated with acute kidney injury following cardiac surgery. J Cardiothorac Vasc Anesth 2010; 24:921-6
25 Biodi-Zoccai GGL, Lotrionte M, Agostini P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006; 27:2667-74
26 BLACKER DJ, FLEMMING KD, LINK MJ, et al. The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery. Mayo Clin Proc 2004; 79:223-9
27 BOERSMA E, POLDERMANS D, BAX JJ et al. Predictors of cardiac events after major vascular surgery. Role of clinical characteristics, dobutamine echocardiography and -blocker therapy. JAMA 2001; 285:1865-73
28 BORGES DJ, GOODNEY PP, VEITH FJ, et al. The vascular study group of New England cardiac risk index (VSG CRI) predicts cardiac complications more accurately than the revised cardiac risk index in vascular surgery patients. J Vasc Surg 2010; 52:674-83
28a BOTTO F, ALONSO-COELLO P, CHAN MT, et al. Myocardial injury after noncardiac surgery: a large international prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology 2014; 120:564-78
29 BOURI S, SHUN-SHIN MJ, COLE GD, et al. Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery. Heart 2013; 100:456-64
30 BREEN P, LEE JW, POMPOSELLI F, PARK KW. Timing of high-risk vascular surgery following coronary artery bypass surgery: A 10-year experience from an academic medical centre. Anaesthesia 2004; 59:422-7
31 BRILAKIS ES, COHEN DJ, KLEIMAN NS, et al. Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evalvuation of Drug-Eluting Stents and Ischemic Events Regiostry. Am Heart J 2011; 161:360-6
32 Brilakis ES, Orford JL, Fasseas P, et al. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 2005, 96: 512-4
32a BRINKMAN W, HERBERT MA, O’BRIEN S, et al. Preoperative -blocker use in coronary artery bypass grafting surgery: national database analysis. JAMA Intern Med 2014; 174:1320-7
33 Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its preoperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Int Med 2005; 257:399-414
34 CALLEJA A, DOMMARAJU S, GADDAM R, et al. Cardiac risk in patients aged > 75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 2010 ; 105 :1159-63
35 CANNON CP, HARRINGTON RA, JAMES S, et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomized double-blind study. Lancet 2010; 375:283-93
36 CARREL T, ENGLBERGER L. Coronary bypass surgery in patients treated with clopidogrel. Is it safe? Curr Opin Cardiol 2009; 24:539-43
37 CATTANEO M. New P2Y12 inhibitors. Circulation 2010; 121:171-9
38 CERQUEIRA MD, WEISSMAN NJ, DILSIZIAN V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105:539-45
39 CHASSOT PG, DELABAYS A, SPAHN DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Brit J Anaesth 2002; 89:747-59
40 CHASSOT PG, DELABAYS A, SPAHN DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99:316-28
41 CHASSOT PG, MARCUCCI C, DELABAYS A, SPAHN DR. Perioperative antiplatelet therapy. Am Fam Physician 2010; 82:1484-9
42 CHATURVEDI S, BRUNO A, FEASBY T, et al. Carotid endarterectomy – an evidence based review: Report of the Therapeutics and technology assessment subcommittee of the Aemrican Academy of Neurology. Neurology 2005; 65:794-801
43 CHOPRA V, WESORICK DH, SUSSMAN JB, et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay. Arch Surg 2012; 147:181-9
44 CHRIST M, SHARKOVA Y, GELDNER G, MAISCH B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest 2005; 128:2944-53
45 COHEN MC, ARETZ TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999; 8:133-9
46 COLLET JP, CUISSET T, RANGE G, et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 2012; 367:2100-9
47 COMFERE T, SPRUNG J, KUMAR MM, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100:636-44
48 Cooke GE, Liu-Stratton Y, Kerketich AK et al. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their coombination. J Am Coll Cardiol 2006; 47:541-6
49 CORIAT P. Renin angiotensin aldosterone systems blockade and perioperative left ventricular function. Semin Cardiothorac Vasc Anesth 2003; 7:55-8
50 CROSSLEY GH, POOLE JE, ROZNER MA, et al. The Heart Rythm Society (HRS) / American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management. Heart Rythm 2011; 8:1114-54
51 CUISSET T, FRERE C, QUILICI J, et al. Comparison of omeprazole and pantoprazole influence on a high 150 mg clopidogrel maintenance dose. J Am Coll Cardiol 2009; 54:1149-53
52 Cywinski JB, Koch CG, Krajewski LP, et al. Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: A propensity-matched comparison with isolated coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2006; 20:796-802
53 DANIAS PG, ROUSSAKIS A, IONNIDIS JP. Diagnostic performance of coronary magnetic resonance angiography as compared against conventional X-ray angiography: a meta-analysis. J Am Coll Cardiol 2004:44:1867-76
54 D’ASCENZO F, BOLLATI M, CLEMENTI F, et al. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221’066 patients, and 4276 thromboses. Int J Cardiol 2013; 167:575-84
55 DAWOOD MM, GUPTA DK, SOUTHERN J, et al. Pathology of fatal perioperative myocardial infarction: implications regarding physiopathology and prevention. Int J Cardiol 1996; 57:35-44
56 DE BENEDETTI E, URBAN P, HAUSER H. Coronarographie par CT-scan en 2009. Rev Méd Suisse 2009; 5:532-7
57 DE BRUYNE B, PIJLS NHJ, KALESAN B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012; 367:991-1001
58 DEJA MA, KARGUL T, DOMARADZKI W, et al. Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo-controlled, randomised trial. J Thorac Cardiovasc Surg 2012; 144:204-9
59 DE LUCA G, DIRKSEN MT, SPAULDING C, et al. Drug-eluting stents vs bare-metal stents in primary angioplasty. A pooled patient-level meta-analysis of randomized trials. Arch Intern Med 2012; 172:611-21
59a DEVEREAUX PJ, CHAN MT, ALONSO-COELLO P, et al. Association between post-operative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012; 307:2295-304
60 DEVEREAUX PJ, MRKOBRADA M, SESSLER DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014 ; 370 :494-503
61 DEVEREAUX PJ, SESSLER DI, LESLIE K, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med 2014; 370:1504-13
62 DEVEREAUX PJ, YANG H, YUSUF S, et al, for the POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE-trial): a randomised controlled trial. Lancet 2008; 371:1839-47
63 DOUKETIS JD, SPYROPOULOS AC, SPENCER FA, et al. Perioperative management of antithrombotic therapy : Antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest 2012 ; 141 (2 suppl) : e326S-50S
64 Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery : a randomized controlled trial (DECREASE-IV). Ann Surg 2009;249:921-6
65 DUPUIS JY, WANG F, NATHAN H, et al. The cardiac anesthesia risk evaluation score. A clinical useful predictor of mortality and morbidity after cardiac surgery. Anesthesiology 2001 ; 94:194-204
66 DURAZZO AES, MACHADO FS, IKEOKA DT, ET AL. Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial. J Vasc Surg 2004; 39:967-76
67 DURST R, BOGOT N, GILON D, et al. Potential role for coronary computerized angiography for assessing preoperative ischemic risk. J Cardiothorac Vasc anesth 2010; 24:348-55
68 EBERLI D, CHASSOT PG, SULSER T et al. Urologic surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol 2010; 183:2128-36
69 ECST: European Carotid Surgery Trialist’s Collaborative Group – Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial. Lancet 1998; 351:1379-87
70 EISENBERG MJ, RICHARD PR, LIBERSAN D, et al. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009; 119:1634-42
71 ELLIS SG, HERTZER NR, YOUNG JR, et al. Angiographic correlates of cardiac death and myocardial infarction complicating major non-thoracic vascular surgery. Am J Cardiol 1996; 77:1126-28
72 ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischemia of arterial origin (ESPRIT): randomized, controlled trial. Lancet 2006; 367:1665-73
73 ETCHELLS E, MEADE M, TOMLINSON G, et al. Semiquantitative dipyridamiole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysis. J Vasc Surg 2002;36:534-40
74 EVANS BA, WIJDICKS EF. High-grade carotid stenosis detected before general surgery: is endarterectomy indicated ? Neurology 2001; 57:1328-30
75 FERES F, COSTA RA, ABIZAID A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents. The OPTIMIZE randomized trial. JAMA 2013; 310:2510-22
76 FERGUSON TB, COOMBS LP, PETERSON ED. Preoperative -blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002; 287:2221-7
77 FERGUSON GG, ELIASZIV M, BARR HW, et al. The North American Symptomatic Carotid Endarterectomy Trial.: Surgical results in 1415 patients. Stroke 1999; 30(9):1751
78 FERINGA HH, BAX JJ, SHOUTEN O, et al. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery. Semin Cardiothorac Vasc Anesth 2006; 10:25-31
79 FERRANDIS R, CASTILLO J, DE ANDRES J, et al. The perioperative management of new direct oral anticoagulants: a question without answer. Thromb Haemost 2013; 110:515-22
80 Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45:456-9
81 FERRARIS VA, SAHA SP, OESTREICH JH, et al. 2012 update to the Society of Thoracic Surgeons Guidelines on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012 ; 94 :1761-81
82 FINTEL DJ. Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options. Vasc Health Risk Manag 2012; 8:77-89
83 FLEISHER LA, FLEISCHMANN KE, AUERBACH AD, et al. 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130:e278-e333
84 FLIER S, BUHRE WF, VAN KLEI WA. Cardioprotective effects of perioperative -blockade in vascular surgery patients: fact or fiction ? Curr Opin Anaesthesiol 2011; 24:104-10
85 FLU WJ, VAN KUIJK JP, CHONCHOL M, et al. Timing of preoperative beta-blocker treatment in vascular patients. J Am Coll Cardiol 2010; 56:1922-9
86 FLU WJ, VAN KUIJK JP, HOEKS SE, et al. Prognostic implications of asymptomatic left ventricular dysfunction in patients undergoing vascular surgery. Anesthesiology 2010; 112:1316-24
87 FORD MK, BEATTIE WS, WIJEYSUNDERA DN. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med 2010; 152:26-35
88 FORRESTER JS. Role of plaque rupture in acute coronary syndromes. Am J Cardiol 2000; 86(Suppl):J15-23
88a FOUCRIER A, RODSETH R, AISSAOUI M, et al. The long-term impact of early cardiovascular therapy intensification for postoperative troponin elevation after major vascular surgery. Anesth Analg 2014; 119:1053-63
89 GALAL W, HOEKS SE, FLU WJ, et al. Relation between preoperative and intraoperative new wall motion abnormalities in vascular surgery patients. Anesthesiology 2010; 112:557-66
90 GARWOOD S. Statins and cardiac surgery. J Cardiothorac Vasc Anesth 2010; 24:909-12
91 GAUSS A, RÖHM HJ, SCHÄUFFELEN A, et al. Electrocardiographic exercise stress testing for cardiac risk assessment in patients undergoing noncardiac surgery. Anesthesiology 2001 ; 94:38-46
92 GILES JW, SEAR JW, FOËX P. Effect of chronic -blockade on peri-operative outcome in patients undergoing non-cardiac surgery: an analysis of observational and case control studies. Anaesthesia 2004; 59:574-83
93 GIRISH M, TRAYNER E, DAMMANN O, et al. Symptom-limited stair climbing as a predictor of postoperative cardiopulmonary complications after high-risk surgery. Chest 2001; 120:1147-51
94 GIROUD D, LI JM, URBAN P, et al. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992; 69:729-32
95 GLANCE LG, LUSTIK SJ, HANNAN EL, et al. The surgical mortality probability model: Derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg 2012; 255:696-702
96 GODET G, RIOU B, BERTRAND M, et al. Does preoperative coronary angioplasty improve perioperative cardiac outcome ? Anesthesiology 2005; 102:739-46
97 GOGARTEN W, VANDERMEULEN E, VAN AKEN H, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010; 27:999-1015
98 GOGBASHIAN A, SEDRAKYAN A, TREASURE T. EuroSCORE: a systematic review of international performance. Eur J Cardiothorac Surg 2004; 25:695-700
99 GREENBAUM AB, GRINES CL, BITTL JA, et al. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: result from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial. Am Heart J 2006; 151:689.e1-689.e10
100 GREGORATOS G, ABRAMS J, EPSTEIN AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pace-makers and antiarrhythmia devices; summary article. Circulation 2002; 106:2145-61
101 Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000; 35:157-63
102 GUPTA PK, GUPTA H, SUNDARAM A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 2011; 124:381-7
103 GURBEL PA, BLIDEN KP, BUTLER K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease. Circulation 2009; 120:2577-85
104 GURBEL PA, BLIDEN KP, BUTLER K, et al. Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies. The RESPOND study. Circulation 2010; 121:1188-99
105 GWON HC, HAHN JY, PARK KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-elunting stents (EXCELLENT study). Circulation 2012 ; 125 :505-13
106 HACKAM DG, GOODMAN SG, ANAND SS. Management of risk in peripheral artery disease: recent therapeutic advances. Am Heart J 2005; 150:35-40
107 HAMM CW, BASSAND JP, AGEWALL S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011; 32:2999-3054
108 HANNAN EL, RACZ MJ, WALFORD G, et al. Long-term outcomes of coronary artery bypass grafting versus stent implantation. N Engl J Med 2005; 352:2174-83
109 Harder S, Klinkhardt U, Alvarez JM. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy. Clin Pharmacokin 2004; 43: 963-81
110 HASSAN SA, HLATCKY MA, BOOTHROYD DB, et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularisation Investigation (BARI). Am J Med 2001; 110:260-6
111 HAWN MT, GRAHAM LA, RICHMAN JS; et al. Risk of major advers cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013; 310:1462-72
112 HEIDBUCHEL H, VERHAMME P, ALINGS M, et al. European Heart Rythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013 ; 15:625-51
113 HILLIS LD, SMITH PK, ANDERSON JL, et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery : A report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:e652-e735
114 HINDLER K, SHAW AD, SAMUELS J, et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105:1260-72
115 HLATKY MA, BOINEAU RE, HIGGINBOTHAM MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989; 64:651-4
116 HOWELL SJ, SEAR JW, FOËX P. Hypertension, hypertensive heart disease and perioperative cardiac risk. Br J Anaesth 2004; 92:570-83
117 Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293 :2126-30
118 JAMBOR C, VON PAPE KW, SPANNAGL M, et al. Multiple Electrode whole blood Aggregometry, PFA-100, and in vivo Bleeding Time for the point-of-care assessment of aspirin-induced platelet dysfunction in the preoperative setting. Anesth Analg 2011; 113:31-9
119 JONER M, FINN AV, FARB A, et al. Pathology of drug-eluting stents in humans. J Am Coll Cardiol 2006 ; 48 :193-202
120 JUUL AB, WETTERSLEV, GLUUD C, et al. Randomized, blinded trial on perioperative metoprolol vs. placebo for diabetic patients undergoing major noncardiac surgery. Circulation 2005; 111:1725
121 KAATZ S, KOUIDES PK, GARCIA DA ; et al. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol 2012 ; 87:S141-S145
122 KANEKO T, SAITO Y, HIKAWA Y, et al. Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischaemia in patients undergoing major abdominal surgery. Br J Anaesth 2001; 86:332-7
123 KAPETANAKIS EI, MEDLAM DA, BOYCE SW, et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist’s panacea or the surgeon’s headache? Eur Heart J 2005; 26: 576-83
124 KATRITSIS DG, IOANNIDIS JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005; 111:2906-12
125 KERTAI MD, BOERSMA E, BAX JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003; 89:1327-34
126 KERTAI MD, BOERSMA E, BAX JJ, et al. Comparison between serum creatinine and creatinine clearance for the prediction of postoperative mortality in patients undergoing major vascular surgery. Clin Nephrol 2003; 39:17-23
127 KERTAI MD, BOUTIOUKOS M, BOERSMA M, et. Aortic stenosis: An underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med 2004; 116:8-13
128 KHETERPAL S, KHODAPARAST O, SHANKS A, et al. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth 2008; 22:180-6
129 KHETERPAL S, O’REILLY M, ENGLESBE MJ, et al. Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery. Anesthesiology 2009; 110:58-66
130 KHETERPAL S, TREMPER KK, HEUNG M, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national dataset. Anesthesiology 2009; 110:505-15
131 KHURI SF, DAKEY J, HENDERSON W, et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 1995; 180:519-31
132 KIM WY, DANIAS PG, STUBER M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; 345:1863-9
133 KLOP RBJ, EIKELBOOM BC, TASKS AC. Screening of the internal carotid arteries in patients with peripheral vascular disaese by colour-flow duplex scanning. Eur J Vasc Surg 1991; 5:41-5
134 KORTE W, CATTANEO M, CHASSOT PG, et al. Perioperative management of antiplatelet therapy in patients with coronary artery disease. Thromb Haemost 2011; 105:743-9
135 Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of Sirolimus-eluting stents. J Am Coll Cardiol 2006; 47:2108-11
136 KOZEK-LANGENECKER SA, AFSHARI A, ALBALADEJO P, et al. Management of severe perioperative bleeding : Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013 ; 30 : 270-82
137 KRISTENSEN SD, KNUUTI J, SARASTE A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J 2014; 35:2383-431
138 KUNADIAN B, THOMLEY AR, TANOS M, DUNNING J. Should clopidogrel be stopped prior to urgent surgery ? Interact Cardiovasc Thorac Surg 2006; 5:630-6
139 LANDESBERG G. The pathophysiology of perioperative myocardial infarction: Facts and perspectives. J Cardiothorac Vasc Anesth 2003; 17:90-100
140 LANDESBERG G, MOSSERI M, WOLF Y, et al. Preoperative Thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulation 2003; 108:177-83
141 LANDESBERG G, MOSSERI M, ZAHGER D, et al. Myocardial infarction following vascular surgery: The role of prolonged, stress-induced, ST-depression type ischemia. J Am Coll Cardiol 2001; 37:1839-45
142 LANDESBERG G, SHATZ V, AKOPNIK I, et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term surviival after major vascular surgery. J Am Coll Cardiol 2003; 42:1547-54
143 Lee th, marcantonio er, mangione cm, ET AL. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-9
144 LEE DC, OZ MC, WEINBERG AD, et al. Appropriate timing of surgical intervention after transmural acute myocardial infarction. J Thorac Cardiovasc Surg 2003; 125:115-9
145 LE MANACH Y, GODET G, CORIAT P, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 2007; 104:1326-33
146 LE MANACH Y, PERREL A, CORIAT P, et al. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 2005; 102:885-91
147 LEONG JY, BAKER RA, SHAH PJ, et al. Clopidogrel and bleeding after coronary artery bypass surgery. Ann Thorac Surg 2005; 80: 928-33
148 Lev EI, Patel RT, Maresh KJ, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention. The role of dual drug resistance. J Am Coll Cardiol 2006; 47:27-33
149 LIAKOPOULOS OJ, CHOI YH, HALDENWANG P, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30’000 patients. Eur Heart J 2008; 29:1548-59
150 Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005, 353 (4), 349-361
151 L’ITALIEN GJ, PAUL SD, HENDEL RC, et al. Development and validation of a Bayesian model for perioperative cardiac risk assesment in a cohort of 1081 vascular surgical candidates. J Am Coll Cardiol 1996; 27:779-86
152 LIVHITS M, GIBBONS MM, DE VIRGILIO C, et al. Coronary revascularization after myocardial infarction can reduce risks of noncardiac surgery. J Am Coll Surg 2011; 212:1018-26
153 LIVHITS M, KO CY, LEONARDI NJ, et al. Risk of surgery following recent myocardial infarction. Ann Surg 2011; 253:857-64
154 LONDON MJ, HUR K, SCHWARTZ GG, HENDERSON WG. Association of perioperative -blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013; 309:1704-13
155 MAHLA E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery. Circ Cardiovasc Interv 2012; 5:261-9
156 MANGANO DT, HOLLENBERG M, FEGERT G, et al. Perioperative myocardial ischemia in patients undergoing non-cardiac surgery. J Am Coll Cardiol 1991; 17:843-57
157 MANGANO DT, LAYUG EL, WALLACE A, et al. Effect of atenolol on mortality and cardiovascular morbidity after non-cardiac surgery : Multicenter study of perioperative ischemia research group. N Engl J Med 1996; 335:1713-20
158 MANN J, DAVIES MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999; 82:265-8
159 MARIN F, GONZALES-GONEJERO R, CAPRANZANO P, et al. Pharmacogenetics in cardiovascular antithrombotic therapy. J Am Coll Cardiol 2009; 54:1041-57
160 MARON DJ, SPERTUS JA, MANCINI J, et al. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Agressive druG Evaluation (COURAGE) trial. Am J Cardiol 2009; 104:1055-62
161 MARROQUIN OC, SELZER F, MULUKUTLA SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008; 358:342-52
162 MASHOUR GA, SHANKS AM, KHETERPAL S. Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology 2011; 114:1289-96
163 MASHOUR GA, SHARIFPOUR M, FREUNDLICH RE, et al. Perioperative metoprolol and risk of stroke after noncardiac surgery. Anesthesiology 2013; 119:1340-6
164 MATYAL R, HESS PE, SUBRAMANIAM R, et al. Perioperative diastolic dysfunction during vascular surgery and its association with postoperative outcome. J Vasc Surg 2009; 50:70-6
165 MAULAZ AB, BEZERRA BC, MICHEL P, et al. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005; 62:1217-20
166 McFALLS EO, WARD HB, MORITZ TE, et al. Coronary artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-804
167 MEGA JL, CLOSE SL, WIVIOTT SD, et al. Cytochrome P450 polymorphisms and response to clopidogrel. N Engl J Med 2009; 360:354-62
168 MEHRAN R, BABER U, STEG PG, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary interventions. PARIS: 2 years results from a prospective observational study. Lancet 2013; 382:1714-22
169 MERRITT JC, BHATT DL. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 2004; 17:21-7
170 METS B. Management of hypotension associated with angiotensin-axis blockade and general anesthesia administration. J Cardiothorac Vasc Anesth 2013; 27:156-67
171 Michlig C, Vu DH, Wasserfallen JB, et al. Three years of haemovigilance in a general university hospital. Transfus Med 2003; 13:63-72
172 MIZUNO K, MIYAMOOTGO A, SATOMURA K, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991; 337:809-12
173 MOHR FW, MORICE MC, KAPPETEIN AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381:629-38
174 MONTALESCOT G, SECHTEM U, ACHENBACH S, et al. 2013 ESC Guidelines on the management of stable coronary artery disease. Eur Heart J 2013; 34:2949-3003
175 MORROW DA, GERSH BJ, BRAUNWALD E. Chronic coronary artery disease. In: ZIPES DP, et al, eds. Braunwald’s heart disease. A textbook of cardiovascular medicine, 7th edition. Philadelphia, Elsevier-Saunders, 2005, 1281-354
176 MOUKARBEL GV, BHATT DL. Antiplatelet therapy and proton pump inhibition: clinician update. Circulation 2012; 125:375-80
177 MUECK W, SCHWERS S, STAMPFUSS J. Rivaroxaban and other novel oral anticoagulants : pharmacokinetics in healthy subject, specific patient populations and relevance of coagulation monitoring. Thrombosis Journal 2013 ; 11 : 10
178 MURPHY SA, ANTMAN EM, WIWIOTT SD, et al. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial. Eur Heart J 2008; 29:2473-9
178a NAGELE P, BROWN F, GAGE BF, et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J 2013; 166:325-32.e1
179 NALYSNYK L, FAHRBACH K, REYNOLDS MW, ZHAO SZ, ROSS S. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 2003; 89:767-72
180 NASHEF SAM, ROQUES F, MICHEL P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13
181 NASHEF SAM, ROQUES F, HAMMILL BG, et al. Validation of European system for cardiac operative risk evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002; 22:101-5
181a NASHEF SAM, ROQUES F, SHARPLES LD, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41:734-45
182 NAYLOR AR, MEHTA Z, ROTHWELL PM, et al. Stroke during coronary artery bypass surgery: A critical review of the role of carotid artery disease. Eur J Vasc Endovasc Surg 2002; 23:283-94
183 NISHIMURA RA, OTTO CM, BONOW RO, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129:e521-e643
184 NISHINA K, MIKAWA K, UESUGI T, et al. Efficacy of clonidine for prevention of perioperative myocardial ischaemia: A critical appraisal and meta-analysis of the litterature. Anesthesiology 2002; 96-323-29
185 Nutall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109:588-95
186 O’HATA H, IIDA H, WATANABE YA, et al. Hemodynamic responses induced by dopamine and dobutamine in anesthetized patients premedicated with clonidine. Anesth Analg 1999; 89:843-8
187 O’KEEFE JH, BARNHART CS, BATEMAN TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995; 75:25D
188 OMRAN H, BAUERSACHS R, RÜBENACKER S, et al. The HAS-BLED score predicts bleeding during bridging of chronic oral anticoagulation: results from the national multicenter BNK Online bRiDging REgistRy (BORDER). Thromb Haemost 2012; 108:65-73
189 OPREA AD, POPESCU WM. ADP-receptor inhibitors in the perioperative period: the Good, the Bad and the Ugly. J Cardiothorac Vasc Anesth 2013; 27: 779-95
190 O’ROURKE DJ, QUINTON HB, PIPER W, et al. for the Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2004; 78:466-70
191 OSCARSSON A, GUPTA A, FREDRIKSON M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled trial. Br J Anaesth 2010; 104:305-12
192 OUATTARA A, BENHAOUA H, LE MANACH Y, et al. Perioperative statin therapy is associated with significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2009; 23:633-8
193 PALMERINI T, BIONDI-ZOCCAI G, DELLA RIVA D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network analysis. Lancet 2012; 379.1393-402
194 PATEL MR, BAILEY SR, BONOW RO, et al. ACCF/SCAI/AATS/ASE/ASNC/HFSA/HRS/SCCM/ SCCT/SCMR/STS 2012 Appropriate use criteria for diagnostic catheterization. J Am Coll Cardiol 2012; 59:1995-2027
195 PAUL SD, EAGLE KA, KUNTZ KM, et al. Concordance of preoperative clinical risk with angiographic severity of coronary artery disease in patients undergoing vascular surgery. Circulation 1996; 94:1561-6
196 PENNEL DJ. Cardiovascular Magnetic resonance. Circulation 2010; 121:692-705
197 PERNOD G, ALBALADEJO P, GODIER A, et al. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor Xa inhibitors : proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013. Arch Cardiovasc Dis 2013 ; 106 :382-93
198 POBBLE Trial Investigators. Perioperative beta-blokcade for patients undergoing vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005; 41:602-9
199 POLDERMANS D, BOERSMA E, BAX JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341:1789-94
200 PRICE MJ, BERGER PB, TEIRSTEIN PS, et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention. The GRAVITAS randomized trial. JAMA 2011; 305:1097-105
201 PRICE MJ, WALDER JS, BAKER BA, et al. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease. J Am Coll Cardiol 2012; 59:2338-43
202 PRIEBE HJ. Triggers of perioperative myocardial ischemia and infarction. Brit J Anaesth 2004; 93:9-20
203 Rabbitts JA, Nutall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008;109: 596-604
204 REGENBOGEN SE, EHRENFELD JM, LIPSITZ SR, et al. Utility of the surgical Apgar Score. Validation in 4119 patients. Arch Surg 2009; 144:30-6
205 REICH DL, HOSSAIN S, KROL M, et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg 2005;101:622-8
206 REILLY DF, McNEELY MJ, DOERNER D, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 1999; 159:2185-92
207 RIDKER PM, DANIELSON E, FONSECA A, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:195-207
208 ROBERTS WT, BAX JJ, DAVIES LC. Cardiac CT and CT coronary angiography: Technology and application. Heart 2008; 94:781-92
209 ROQUES F, MICHEL P, GOLDSTONE AR, NASHEF SAM. The logistic EuroSCORE. Eur Heart J 2003; 24:882-3
210 ROQUES F, NASHEF SAM, MICHEL P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15 :816-23
211 ROZNER MA. The patient with a cardiac pacemaker or implanted defibrillator and management during anaesthesia. Curr Opin Anaesthesiol 2007; 20:261-8
212 SABATE S, MASES A, GUILERA N, et al. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth 2011; 107:879-90
213 SACCO RL, ADAMS R, ALBERS G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37:577-617
214 SAVONITTO S, CARACCIOLO M, CATTANEO M, DE SERVI S. Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost 2011; 9:2133-42
215 SAVONITTO S, D’URBANO M, CARACCIOLO M, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of “bridging” antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 2010; 104:285-91
216 SCHOUTEN O, VON DOMBURG RT, BAX JJ, et al. Noncardiac surgery after coronary stenting: Early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49:122-4
217 SCHULTZ S, SCHUSTER T, MEHILL J, et al. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. Eur Heart J 2009; 30:2714-21
218 Seki M, Kashimoto S, Nagata O, et al. Are the incidences of cardiac events during noncardiac surgery Japan the same as in the United States and Europe ? Anesth Analg 2005, 100: 1236-1240
219 Serruys PW, Kutryk MJB, Ong ATL. Coronary artery stents. N Engl J Med 2006; 354:483-95
220 SHARMA AK, AJANI AE, HAMWI SM, et al. Major noncardiac surgery following coronary stenting: When is it safe to operate ? Catheter Cardiovasc Interv 2004; 63:141-5
221 SIBBING D, BRAUN S, MORATH T, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009; 53:849-56
222 SIDDIQI O, FAXON DP. Very late stent thrombosis: current concepts. Curr Opin Cardiol 2012; 27:634-41
223 SIEGAL D, YUDIN J, KAATZ S, et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists : systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012 ; 126 :1630-9
224 Simon T, Verstuyft C, Mary-Krause M, et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009; 360:411-3
225 SINCLAIR RCF, BATTERHAM AM, DAVIES S, et al. Vakidity of the 6-min walk test in prediction of the anaerobic threshold before major non-cardiac surgery. Br J Anaesth 2012; 108:30-5
226 Society of Thoracic Surgeons Database 2002
227 SOUSA-UVA M, STOREY R, HUBER K, et al. Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery. Eur Heart J 2014; 35:1510-4
228 STALENHOEF AFH. The benefit of statins in non-cardiac vascular surgery patients. J Vasc Surg 2009; 49:260-5
229 STEG PG, JAMES SK, ATAR D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33:2569-619
230 STEIN PD, YAEKOUB AY, MATTA F, et al. 64-slice CT for diagnosis of coronary artery disease: A systematic review. Am J Med 2008; 121:715-25
231 STETTLER C, WANDEL S, ALLEMAN S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007; 370:937-48
232 STEVENS RD, BURRI H, TRAMER MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: A quantitative systematic review. Anesth Analg 2003; 97:623-33
233 STONE ME, SALTER B, FISCHER A. Perioperative management of patients with cardiac implantable electronic devices. Br J Anaesth 2011; 107(S1): i16-i26
234 Surgenor SD, Kramer RS, Olmstead EM, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009; 108:1741-1746
235 TAYLOR K, FILGATE R, GUO DY, et al. A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs. BJU Inter 2011 ; 108(S1):45-50
236 TEN BROECKE PWC, DE HERT SG, MERTENS E, ADRIAENSEN HF. Effect of preoperative -blockade on perioperative mortality in coronary surgery. Br J Anaesth 2003; 90:27-31
237 TURPIE AG, KREUTZ R, LLAU J, et al. Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor. Thromb Haemost 2012; 108:876-86
238 VAHANIAN A, ALFIERI O, ANDREOTTI F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33:2451-96
239 VALGIMIGLI M, CAMPO G, MONTI M, et al (PRODIGY Investigators). Short- versus long-term duration of dual antiplatelet therapy after coronary stenting: a randomized, multi-center trial. Circulation 2012; 125:2015-26
240 VAN DER LINDEN J, LINDVALL G, SARTIPY U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: A double-blind, placebo-controlled, randomized clinical trial. Circulation 2005; 112:I276-I280
241 VAN DIEPEN S, BAKAL JA, McALISTER FA, et al. Mortality and readmission of patients with heart failure, atrial fibrillation or coronary artery disease undergoing noncardiac surgery. Circulation 2011; 124:289-96
242 VAN KLEI WA, BRYSON GL, YANG H, FORSTER AJ. Effect of -blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty. Anesthesiology 2009; 111:717-24
243 VAN KUIJK JP, FLU WJ, SCHOUTEN O, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009; 104:1229-34
243a VAN WAES JA, NATHOE HM, DE GRAAFF JC, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation 2013; 127:2264-71
244 Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and non-cardiac surgery – a prospective outcome study. Br J Anaesth 2006; 96:686-93
245 VON HOMEYER P, SCHWINN DA. Pharmacogenomics of -adrenergic receptor. Physiology and response to -blockade. Anesth Analg 2011; 113:1305-18
246 WALLACE AW, AU S, CASON BA. Association of the pattern of use of perioperative -blockade and postoperative mortality. Anesthesiology 2010; 113:794-805
247 WALLENTIN L. P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 2009; 30:1964-77
248 WALLENTIN L, BECKER RC, BUDAJ A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361:1045-57
249 WALSH M, DEVEREAUX PJ, GARG AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery. Anesthesiology 2013; 119:507-15
250 WANG L, McLEOD HL, WEINSHILBOUM RM. Genomics and drug response. N Engl J Med 2011; 364:1144-53
251 WARD HB, KELLY RF, THOTTAPARUTHU L, et al.Coronary artery bypass grafting is superior to percutaneous intervention in prevention of perioperative myocardial infarction during subsequent vascular surgery. Ann Thorac Surg 2006; 82:795-800
252 WEINTRAUB WS, SPERTUS JA, KOLM P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008; 359:677-87
253 WEISSMAN NJ, LEVANGIE MW, GUERRERO JL, et al. Effect of -blockade on dobutamine stress echocardiography. Am Heart J 1996; 131:698-703
254 WELTEN GM, SCHOUTEN O, CHONCHOL M, et al. Temporary worsening of renal function after aortic surgery is associated with higher long-term mortality. Am J Kidney Dis 2007; 50:219-28
255 WESTENDORF JB, GELBRICHT V, FORSTER K, et al. Peri-interventional management of novel oral anticoagulants in daily care : results from prospective Dresden NOAC registry. Eur Heart J 2014 ; 35:1888-96
256 WIESBAUER F, SCHLAGER O, DOMANOVITS H, et al. Perioperative -blockers for preventing surgery-related mortality and morbidity: A systematic review and meta-analysis. Anesth Analg 2007; 104:27-41
257 Wijeysundera DN, BEATTIE WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: A meta-analysis. Anesth Analg 2003; 97:634-41
258 WIJEYSUNDERA DN, BEATTIE WS, WIJEYSUNDERA HC, et al. Duration of preoperative beta-blockade and outcomes after major elective noncardiac surgery. Can J Cardiol 2014; 30:217-23
259 WIJEYSUNDERA DN, DUNCAN D, NKONDE-PRICE, et al. Perioperative beta-blockade in noncardiac surgery: A systematic review for the 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014 ; 64 :2406-25
260 WIJEYSUNDERA DN, WIJEYSUNDERA HC, YUN L, et al. Risk of elective major noncardiac surgery after coronary stent insertion. A population-based study. Circulation 2012; 126:1355-62
261 WIJNS W, KOHL P, DANCHIN N, et al. Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31:2501-55
262 WIN HK, CALDERA AF, MARESH K, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297:2001-9
263 Winchester DE, WEN X, BREARLEY WD, et al. Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: A meta-analysis of randomized trials performed in the era of new stents and thienopyridines. J Am Coll Cardiol 2011; 57:1190-9
264 Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357:2001-15
265 WYSOKINSKI WE, McBANE RD. Periprocedural bridging management of anticoagulation. Circulation 2012 ; 126 :486-90
266 YADAV M, PALMERINI T, CAIXETA A, et al. Prediction of coronary risks by SYNTAX and derived scores. J Am Coll Cardiol 2013; 62:1219-30
267 Yang HR K, RAYMER K, Butler R, et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152:983-90
268 YENDE S, WUNDERINK RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29:2271-5
269 YUSUF S, RANGARAJAN S, TEO K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 2014; 371:818-27
high-income countries. N Engl J Med 2014; 371:818-27
270 ZANNI MV, SCHOUTEN J, GRINSPOON SK, REISS P. Risk of coronary artery disease in patients with HIV infection. Nat Rev Cardiol 2014; 11:728-41
271 ZAUGG M, BESTMANN L, WACKER J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome int at-risk patients undergoing surgery with spinal block. Anesthesiology 2007; 107:33-44
272 ZILE MR, BRUTSAERT DL. New concept in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis, and measurement of diastolic function. Circulation 2002; 105:1387-93